TYSABRI Overview
- Year Founded
-
2004
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
TYSABRI General Information
Description
Manufacturer of multiple sclerosis medicine based in Research Triangle Park, North Carolina. The company offers a prescription medicine used to treat adults with relapsing forms of multiple sclerosis including clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease.
Contact Information
Website
www.tysabri.com(Operating Subsidiary)
Corporate Office
- 5000 Davis Drive
- P.O. Box 13919
- NC 27709
- United States
Corporate Office
- 5000 Davis Drive
- P.O. Box 13919
- NC 27709
- United States
TYSABRI Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
TYSABRI Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
TYSABRI FAQs
-
When was TYSABRI founded?
TYSABRI was founded in 2004.
-
Where is TYSABRI headquartered?
TYSABRI is headquartered in NC.
-
What industry is TYSABRI in?
TYSABRI’s primary industry is Pharmaceuticals.
-
Is TYSABRI a private or public company?
TYSABRI is a Private company.
-
What is the current valuation of TYSABRI?
The current valuation of TYSABRI is .
-
What is TYSABRI’s current revenue?
The current revenue for TYSABRI is .
-
Who are TYSABRI’s investors?
Elan has invested in TYSABRI.
-
When was TYSABRI acquired?
TYSABRI was acquired on 02-Apr-2013.
-
Who acquired TYSABRI?
TYSABRI was acquired by Biogen.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
